Vsee Health

Vsee Health FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Vsee Health (VSEE) as of Nov 2, 2026 is 23.62 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 10.13 % — a change of 133.22% (higher).

FCF Conversion

23.62 %

YoY

133.22%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Vsee Health is 2025 23.62 % . FCF Conversion Rate (FCF/EBITDA) of Vsee Health was 2024 10.13 % . It decreases by 133.22% higher compared to the previous year.

The Vsee Health FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2020
304.82 USD
Jan 1, 2021
-126.10 USD
Jan 1, 2022
173.76 USD
Jan 1, 2023
16.93 USD
Jan 1, 2024
10.13 USD
Jan 1, 2025
23.62 USD
The Vsee Health FCF Conversion history
YEARFCF ConversionYoY
23.62 %+133.22%
10.13 %-40.16%
16.93 %-90.26%
173.76 %-237.80%
-126.10 %-141.37%
304.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vsee Health Stock analysis

What does Vsee Health do? Vsee Health Inc generates revenue through its subsidiaries VSee and iDoc. VSee offers a no-code SaaS platform enabling clinicians and enterprises to build telehealth workflows without programming, providing patient engagement, clinician staffing, remote physical exams, and AI solutions for telesitters and telenursing. iDoc operates as an acute care organization delivering 24/7 neurointensive care, cardiac surgery ICU, and stroke ICU services, offering teleneurointensivists for neuro-critical care. The company's products target healthcare providers seeking efficient telehealth integration and specialized critical care services. VSee's clients include hospitals and healthcare enterprises needing rapid telehealth system deployment, while iDoc serves hospitals requiring specialized neuro-critical care teams. The telehealth platform caters to clinics and hospitals aiming to enhance patient engagement and remote monitoring capabilities. iDoc's services are specifically utilized by facilities managing neuro-ICU, CSICU, and stroke ICU cases, providing expert staffing for critical neurological conditions. The company monetizes through subscription-based SaaS models for VSee's telehealth platform and direct service fees for iDoc's acute care services. VSee's no-code solution appeals to healthcare organizations looking to avoid development costs, while iDoc's specialized staffing model addresses gaps in critical care staffing for neurological emergencies. Both segments target healthcare institutions requiring scalable, specialized digital health solutions. Vsee Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vsee Health stock

FCF Conversion Rate (FCF/EBITDA) of Vsee Health is 23.62 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Vsee Health changed from 10.13 % to 23.62 %, representing a 133.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Vsee Health since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Vsee Health with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Vsee Health

All Key Metrics — Vsee Health